Getting the study drug at the right time is challenging for any clinical trial, and this is more prominent with multi-regional clinical trials. To import and have the IMPs and ancillaries at the clinical trial sites in time, the sponsors need to have the right people, processes, facilities, and technology in place. Generally, the sites […]

Read More →

The conduct of clinical trials is a demanding process. This requires not only the hiring of resources to perform various activities but also the material to support to actually execute different activities and processes. Some of these materials can be investigational products. But, a vast number of products could be non-investigational products required for the […]

Read More →

In the last few decades, there is a growing appreciation for nutraceuticals and dietary supplements’ role in Japan to prevent health risks and improve health quality. The Japanese nutraceutical industry, such as dietary supplements and functional foods, grew at an average of 15 percent per year. In 2019, Japan’s health-related food market was the third-largest […]

Read More →

Do you know, according to clinicaltrials.gov, a total of 354,130 clinical trials were registered worldwide with 71,256 ongoing clinical trials as recorded on Oct-2020? The number of clinical trials is increasing year by year from 56.16k in 2017 to 60.69k in 2018. In the USA, more than 2.3+ million people participate in approximately 80,000+ clinical […]

Read More →

Drug development is a lengthy, complex, and costly process, entrenched with a high degree of uncertainty that a drug will actually succeed and reach the market successfully. So for this, you need a proper drug development strategy to avoid uncertainties and complete clinical trials in time with quality data. Drug development is the process of […]

Read More →

Drug development is the process of bringing a new pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery. The drug development process starts from drug discovery to getting market approval and post-marketing studies. This entire process of medical device/drug development takes years and completely depends on […]

Read More →

The drug approval process in Japan is less complex and easy when compared to some other countries beyond the language barriers. The PMDA along with regulatory aspects also provides consultation to sponsors to help understand the requirements and the stepwise drug approval process. This makes many manufacturers choose Japan as their drug market. Japan’s pharmaceutical […]

Read More →